Next report date
Report period
H1 2024
EPS estimate
0.07GBP
Revenue estimate
1.11 BGBP
0GBP
38.86 MGBP
2.21 BGBP
236.39 M
About UNIPHAR PLC
Sector
Industry
CEO
Gerard Rabbette
Website
Headquarters
Dublin
Founded
1994
ISIN
IE00BJ5FQX74
FIGI
BBG00PGDSG11
Uniphar Plc engages in the provision of services within the pharmaceutical and healthcare sector. It operates through the following segments: Commercial and Clinical; Product Access; and Supply Chain and Retail. The Commercial and Clinical segment provides outsourced services specifically sales, marketing, and multichannel account management to pharmaco-medical manufacturers; and distribution and support services to medical device manufacturers. The Product Access segment offers demand and exclusive access services. The Supply Chain and Retail segment focuses on pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons. The company was founded in 1967 and is headquartered in Dublin, Ireland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of UPR is 224 GBX — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange UNIPHAR PLC ORD EUR0.08 (CDI) stocks are traded under the ticker UPR.
UNIPHAR PLC ORD EUR0.08 (CDI) is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
UPR stock is 0.90% volatile and has beta coefficient of 1.01. Check out the list of the most volatile stocks — is UNIPHAR PLC ORD EUR0.08 (CDI) there?
UPR earnings for the last quarter are 0.06 GBX per share, whereas the estimation was 0.07 GBX resulting in a −6.21% surprise. The estimated earnings for the next quarter are 0.10 GBX per share. See more details about UNIPHAR PLC ORD EUR0.08 (CDI) earnings.
UNIPHAR PLC ORD EUR0.08 (CDI) revenue for the last quarter amounts to 1.07 B GBX despite the estimated figure of 1.02 B GBX. In the next quarter revenue is expected to reach 1.13 B GBX.
Yes, you can track UNIPHAR PLC ORD EUR0.08 (CDI) financials in yearly and quarterly reports right on TradingView.
UPR stock has risen by 1.36% compared to the previous week, the month change is a 2.27% fall, over the last year UNIPHAR PLC ORD EUR0.08 (CDI) has showed a 13.15% decrease.
UPR net income for the last quarter is 25.84 M GBP, while the quarter before that showed 12.90 M GBP of net income which accounts for 100.31% change. Track more UNIPHAR PLC ORD EUR0.08 (CDI) financial stats to get the full picture.
Today UNIPHAR PLC ORD EUR0.08 (CDI) has the market capitalization of 589.94 M, it has increased by 3.29% over the last week.
UNIPHAR PLC ORD EUR0.08 (CDI) dividend yield was 0.68% in 2023, and payout ratio reached 11.14%. The year before the numbers were 0.56% and 10.40% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, UPR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UNIPHAR PLC ORD EUR0.08 (CDI) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So UNIPHAR PLC ORD EUR0.08 (CDI) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating UNIPHAR PLC ORD EUR0.08 (CDI) stock shows the sell signal. See more of UNIPHAR PLC ORD EUR0.08 (CDI) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on UNIPHAR PLC ORD EUR0.08 (CDI) future price: according to them, UPR price has a max estimate of 427.25 GBX and a min estimate of 290.53 GBX. Read a more detailed UNIPHAR PLC ORD EUR0.08 (CDI) forecast: see what analysts think of UNIPHAR PLC ORD EUR0.08 (CDI) and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UNIPHAR PLC ORD EUR0.08 (CDI) EBITDA is 97.77 M GBP, and current EBITDA margin is 4.42%. See more stats in UNIPHAR PLC ORD EUR0.08 (CDI) financial statements.